Search results
Results from the WOW.Com Content Network
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal.
11.1 Mechatronics. 11.2 Petroleum ... This is a representative list of academic journals and magazines in engineering and its various subfields. ... Electronic Design;
The development of designer drugs may be considered a subfield of drug design. The exploration of modifications to known active drugs—such as their structural analogues, stereoisomers, and derivatives—yields drugs that may differ significantly in effects from their "parent" drug (e.g., showing increased potency, or decreased side effects).
Schedule X is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules introduced in 1945. These are drugs which cannot be purchased over the counter without a valid prescription of a Registered Medical Practitioner (RMP). Also, the retailer has to preserve the prescription for a period of two years. [1]
Schedule J: Contains a list of various diseases and medical conditions that cannot be treated under any drug currently in market. No drug may legally claim to treat these diseases. [3] Schedule X: Schedule X lists addictive drugs (e.g. narcotics, psychotropics [6]) having medicinal uses that must be kept under lock and key. All the regulations ...
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs , ranked by sales.
The phrase "drug design" is similar to ligand design (i.e., design of a molecule that will bind tightly to its target). [6] Although design techniques for prediction of binding affinity are reasonably successful, there are many other properties, such as bioavailability, metabolic half-life, and side effects, that first must be optimized before a ligand can become a safe and effictive drug.